Comparison of different surgical techniques for pelvic floor repair in elderly women: a multi-institutional study.


Journal

Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213

Informations de publication

Date de publication:
04 2019
Historique:
received: 12 06 2018
accepted: 01 02 2019
pubmed: 23 2 2019
medline: 7 3 2020
entrez: 22 2 2019
Statut: ppublish

Résumé

The prevalence of pelvic organ prolapse (POP) is increasing. The number of women aged 70-80 years requiring surgical management for POP is also increasing. The purpose of this study was to compare the complications associated with three pelvic organ prolapse repair methods, sacrocolpopexy (SCP), native tissue repair (NTR), and vaginal mesh repair (VMR), in women aged 70-80 years. We performed a multi-institutional retrospective analysis of 213 women who underwent POP surgical repairs between December 2012 and December 2017. Treatment-related complications were classified using the ClavienDindo grading system and compared among the three groups. Perioperative data, anatomical success rates, patient satisfaction, and postoperative complication data were collected during the follow-up period, which lasted up to 12 months. Of 213 patients, 70 (33%) underwent SCP, 85 (40%) underwent NTR, and 58 (28%) underwent VMR. By postoperative day 30, the all-inclusive complication rate was lower in the SCP group than in the NTR or VMR group; however, there was no between-group difference in complication grade. The VMR group underwent fewer concomitant hysterectomies than the other groups, and operative time was the longest for SCP. Overall, recovery time, anatomical success rate, and patient satisfaction were comparable for all three repairs. All three surgical techniques were equivalent in patient satisfaction, anatomical success rate, and complication rate. SCP should be recommended to elderly women who meet criteria for prolonged general anesthesia, as it was associated with fewer perioperative complications than NTR and VMR.

Identifiants

pubmed: 30788571
doi: 10.1007/s00404-019-05076-1
pii: 10.1007/s00404-019-05076-1
doi:

Banques de données

ClinicalTrials.gov
['NCT03445442']

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1007-1013

Auteurs

Brannwel Tibi (B)

Department of Urology, Hôpital Pasteur 2, CHU Nice, University of Nice-Sophia Antipolis, 30 Voie Romaine, 06000, Nice, France. tibi.b@chu-nice.fr.
Department of General Surgery and Gynecology, Diaconesses-Croix Saint Simon Hospital Paris, Paris, France. tibi.b@chu-nice.fr.

Etienne Vincens (E)

Department of General Surgery and Gynecology, Diaconesses-Croix Saint Simon Hospital Paris, Paris, France.

Matthieu Durand (M)

Department of Urology, Hôpital Pasteur 2, CHU Nice, University of Nice-Sophia Antipolis, 30 Voie Romaine, 06000, Nice, France.

Imad Bentellis (I)

Department of Urology, Hôpital Pasteur 2, CHU Nice, University of Nice-Sophia Antipolis, 30 Voie Romaine, 06000, Nice, France.

Delphine Salet-Lizee (D)

Department of General Surgery and Gynecology, Diaconesses-Croix Saint Simon Hospital Paris, Paris, France.

Aminata Kane (A)

Department of General Surgery and Gynecology, Diaconesses-Croix Saint Simon Hospital Paris, Paris, France.

Pierre Gadonneix (P)

Department of General Surgery and Gynecology, Diaconesses-Croix Saint Simon Hospital Paris, Paris, France.

François Severac (F)

Department of Public Health, University Hospital of Strasbourg, Strasbourg, France.

Youness Ahallal (Y)

Department of Urology, Hôpital Pasteur 2, CHU Nice, University of Nice-Sophia Antipolis, 30 Voie Romaine, 06000, Nice, France.

Daniel Chevallier (D)

Department of Urology, Hôpital Pasteur 2, CHU Nice, University of Nice-Sophia Antipolis, 30 Voie Romaine, 06000, Nice, France.

Richard Villet (R)

Department of General Surgery and Gynecology, Diaconesses-Croix Saint Simon Hospital Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH